Efficacy of Sovodak in the Management of Patients Co-infected with HIV/HCV

Purpose: Sofosbuvir (SOF) and daclatasvir (DOC) are suggested for the treatment of hepatitis C virus (HCV) in patients with concomitant HCV and human immunodeficiency virus (HIV). In 2016, Sovodak tablet a combination of SOF and DOC was introduced. In the present study we assessed the effectiveness...

Descripción completa

Detalles Bibliográficos
Autores principales: Somi, Mohammad Hossein, Sepehri, Bita, Nikniaz, Zeinab, Sedghi, Roya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tabriz University of Medical Sciences 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539312/
https://www.ncbi.nlm.nih.gov/pubmed/33072543
http://dx.doi.org/10.34172/apb.2020.080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539312/
https://www.ncbi.nlm.nih.gov/pubmed/33072543
http://dx.doi.org/10.34172/apb.2020.080

Ejemplares similares